Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,314,000 | 9,086,000 | 8,140,000 | 9,595,000 | 8,975,000 |
| Marketable Securities | 9,000 | 1,160,000 | 960,000 | 300,000 | 621,000 |
| Receivables | 3,995,000 | 3,811,000 | 4,590,000 | 4,803,000 | 3,798,000 |
| Inventories | 1,008,000 | 1,048,000 | 1,104,000 | 1,150,000 | 1,172,000 |
| Income taxes - deferred | 524,000 | 1,104,000 | 1,075,000 | 766,000 | 1,419,000 |
| TOTAL | $17,555,000 | $17,794,000 | $17,329,000 | $17,848,000 | $16,543,000 |
| Non-Current Assets | |||||
| PPE Net | 2,432,000 | 2,387,000 | 2,333,000 | 2,298,000 | 2,244,000 |
| Investments And Advances | 124,000 | 130,000 | 119,000 | 118,000 | 123,000 |
| Intangibles | 7,542,000 | 7,939,000 | 8,073,000 | 8,167,000 | 8,192,000 |
| Other Non-Current Assets | 801,000 | 795,000 | 803,000 | 767,000 | 1,150,000 |
| TOTAL | $10,899,000 | $11,251,000 | $11,328,000 | $11,350,000 | $11,709,000 |
| Total Assets | $28,454,000 | $29,045,000 | $28,657,000 | $29,198,000 | $28,252,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 323,000 | 271,000 | 20,000 | 431,000 | 434,000 |
| Accounts payable and accrued liabilities | 6,312,000 | 6,046,000 | 6,196,000 | 6,448,000 | 6,441,000 |
| TOTAL | $6,635,000 | $6,317,000 | $6,216,000 | $6,879,000 | $6,875,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,469,000 | 14,470,000 | 14,386,000 | 14,292,000 | 14,375,000 |
| Other Non-Current Liabilities | 2,705,000 | 3,040,000 | 3,358,000 | 3,535,000 | 3,425,000 |
| TOTAL | $17,174,000 | $17,510,000 | $17,744,000 | $17,827,000 | $17,800,000 |
| Total Liabilities | $23,809,000 | $23,827,000 | $23,960,000 | $24,706,000 | $24,675,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,593,265 | 1,591,699 | 1,590,066 | 1,588,519 | 1,590,862 |
| Common Shares | 16,000 | 16,000 | 16,000 | 16,000 | 16,000 |
| Retained earnings | 2,131,000 | 2,299,000 | 1,874,000 | 1,567,000 | 1,081,000 |
| Other shareholders' equity | -913,000 | -420,000 | -426,000 | -442,000 | -981,000 |
| TOTAL | $4,645,000 | $5,218,000 | $4,697,000 | $4,492,000 | $3,577,000 |
| Total Liabilities And Equity | $28,454,000 | $29,045,000 | $28,657,000 | $29,198,000 | $28,252,000 |